Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25258
Title: | NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns. | Austin Authors: | Stamberger, Hannah;Hammer, Trine B;Gardella, Elena;Vlaskamp, Danique R M;Bertelsen, Birgitte;Mandelstam, Simone;de Lange, Iris;Zhang, Jing;Myers, Candace T;Fenger, Christina;Afawi, Zaid;Almanza Fuerte, Edith P;Andrade, Danielle M;Balcik, Yunus;Ben Zeev, Bruria;Bennett, Mark F ;Berkovic, Samuel F ;Isidor, Bertrand;Bouman, Arjan;Brilstra, Eva;Busk, Øyvind L;Cairns, Anita;Caumes, Roseline;Chatron, Nicolas;Dale, Russell C;de Geus, Christa;Edery, Patrick;Gill, Deepak;Granild-Jensen, Jacob Bie;Gunderson, Lauren;Gunning, Boudewijn;Heimer, Gali;Helle, Johan R;Hildebrand, Michael S ;Hollingsworth, Georgie;Kharytonov, Volodymyr;Klee, Eric W;Koeleman, Bobby P C;Koolen, David A;Korff, Christian;Küry, Sébastien;Lesca, Gaetan;Lev, Dorit;Leventer, Richard J;Mackay, Mark T;Macke, Erica L;McEntagart, Meriel;Mohammad, Shekeeb S;Monin, Pauline;Montomoli, Martino;Morava, Eva;Moutton, Sebastien;Muir, Alison M;Parrini, Elena;Procopis, Peter;Ranza, Emmanuelle;Reed, Laura;Reif, Philipp S;Rosenow, Felix;Rossi, Massimiliano;Sadleir, Lynette G;Sadoway, Tara;Schelhaas, Helenius J;Schneider, Amy L ;Shah, Krati;Shalev, Ruth;Sisodiya, Sanjay M;Smol, Thomas;Stumpel, Connie T R M;Stuurman, Kyra;Symonds, Joseph D;Mau-Them, Frederic Tran;Verbeek, Nienke;Verhoeven, Judith S;Wallace, Geoffrey;Yosovich, Keren;Zarate, Yuri A;Zerem, Ayelet;Zuberi, Sameer M;Guerrini, Renzo;Mefford, Heather C;Patel, Chirag;Zhang, Yue-Hua;Møller, Rikke S;Scheffer, Ingrid E | Affiliation: | Epilepsy Research Centre Department of Neurosciences, Queensland Children's Hospital, Brisbane, QLD, Australia The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia Department of Medical Biology University of Melbourne, Melbourne, VIC, Australia Royal Children's Hospital, Melbourne, VIC, Australia Murdoch Children's Research Institute, Melbourne, VIC, Australia Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia Department of Radiology, University of Melbourne, Melbourne, VIC, Australia Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia Department of Epilepsy Genetics, Danish Epilepsy Centre Filadelfia, Dianalund, Denmark Institute for Regional Health Services Research, University of Southern Denmark, Odense, Denmark Applied and Translational Neurogenomics group, Center for Molecular Neurology, VIB, and Department of Neurology, University Hospital of Antwerp, University of Antwerp, Antwerpen, Belgium Lyon University Hospitals, Departments of Genetics, Lyon, France INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, GENDEV Team, Bron, France Edmond and Lily Safra Children's Hospital, Pediatric Neurology Unit, Tel-Hashomer, Israel Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel University of Groningen, University Medical Center Groningen, Department of Neurology, Groningen, the Netherlands University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands Clinical Genetic Department, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark T.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, Sydney, Australia CPDPN, Pôle mère enfant, Maison de Santé Protestante Bordeaux Bagatelle, Talence, France INSERM UMR1231 GAD, FHU-TRANSLAD, Université de Bourgogne, Dijon, France Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel Institute of Medical Genetics, Wolfson Medical Center, Holon, Israel Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK School of Medicine, University of Queensland, Brisbane, QLD, Australia White Matter Disease Care, Pediatric Neurology Unit, Dana-Dwak Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Genetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia UF Innovation en diagnostic genomique des maladies rares, CHU Dijon Bourgogne, Dijon, France Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands Department of Pediatrics, Peking University First Hospital, Beijing, China Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA Department of Epilepsy Genetics, Danish Epilepsy Centre Filadelfia, Dianalund, Denmark Tel Aviv University Medical School, Tel Aviv, Israel Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, and Center for Personalized Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, Frankfurt am Main, Germany Service de génétique médicale, CHU Nantes, Nantes, France Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands Section for Medical Genetics, Telemark Hospital, Skien, Norway Service de Neuropédiatrie, Pôle de Médecine et Spécialités Médicales, CHRU de Lille, Lille, France Lyon University Hospitals, Departments of Genetics, Lyon, France University Medical Centre Groningen, Department of Genetics, Groningen, The Netherlands Child and Youth, Randers Regional Hospital, Randers, Denmark Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA Stichting Epilepsie Instellingen Nederland, Zwolle, The Netherlands Section for Medical Genetics, Telemark Hospital, Skien, Norway Clinical Hospital "Psychiatry", Kyiv, Ukraine Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands Pediatric Neurology Unit, University Hospitals, Geneva, Switzerland Service de génétique médicale, CHU Nantes, Nantes, France Lyon University Hospitals, Departments of Genetics, Lyon, France Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA Medical Genetics, St George's University Hospitals NHS FT, Cranmer Tce, London, United Kingdom Lyon University Hospitals, Departments of Genetics, Lyon, France Department of Neuroscience, Pharmacology and Child Health, Children's Hospital A. Meyer and University of Florence, Florence, Italy Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA Department of Neuroscience, Pharmacology and Child Health, Children's Hospital A. Meyer and University of Florence, Florence, Italy Medigenome, Swiss Institute of Genomic Medicine, Geneva, Switzerland Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, and Center for Personalized Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, Frankfurt am Main, Germany Department of Paediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada Stichting Epilepsie Instellingen Nederland, Zwolle, The Netherlands One Centre of Genetics, Vadodara, India Neuropaediatric Unit, Shaare Zedek Medical Centre, Hebrew University School of Medicine, Jerusalem, Israel Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom and Chalfont Centre for Epilepsy, Bucks, UK Institut de Génétique Médicale, Hopital Jeanne de Flandre, Lille University Hospital, Lille, France Department of Clinical Genetics and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands Academic Center for Epileptology, Kempenhaege, Department of Neurology, Heeze, The Netherlands Molecular Genetics Lab, Wolfson Medical Center, Holon, Israel Section of Genetics and Metabolism, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR, USA Department of Neuroscience, Pharmacology and Child Health, Children's Hospital A. Meyer and University of Florence, Florence, Italy Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA Department of Pediatrics, Peking University First Hospital, Beijing, China |
Issue Date: | Feb-2021 | Date: | 2020-11-04 | Publication information: | Genetics in Medicine 2021; 23(2): 363-373 | Abstract: | Pathogenic variants in the X-linked gene NEXMIF (previously KIAA2022) are associated with intellectual disability (ID), autism spectrum disorder, and epilepsy. We aimed to delineate the female and male phenotypic spectrum of NEXMIF encephalopathy. Through an international collaboration, we analyzed the phenotypes and genotypes of 87 patients with NEXMIF encephalopathy. Sixty-three females and 24 males (46 new patients) with NEXMIF encephalopathy were studied, with 30 novel variants. Phenotypic features included developmental delay/ID in 86/87 (99%), seizures in 71/86 (83%) and multiple comorbidities. Generalized seizures predominated including myoclonic seizures and absence seizures (both 46/70, 66%), absence with eyelid myoclonia (17/70, 24%), and atonic seizures (30/70, 43%). Males had more severe developmental impairment; females had epilepsy more frequently, and varied from unaffected to severely affected. All NEXMIF pathogenic variants led to a premature stop codon or were deleterious structural variants. Most arose de novo, although X-linked segregation occurred for both sexes. Somatic mosaicism occurred in two males and a family with suspected parental mosaicism. NEXMIF encephalopathy is an X-linked, generalized developmental and epileptic encephalopathy characterized by myoclonic-atonic epilepsy overlapping with eyelid myoclonia with absence. Some patients have developmental encephalopathy without epilepsy. Males have more severe developmental impairment. NEXMIF encephalopathy arises due to loss-of-function variants. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/25258 | DOI: | 10.1038/s41436-020-00988-9 | ORCID: | 0000-0002-2311-2174 |
Journal: | Genetics in Medicine | PubMed URL: | 33144681 | Type: | Journal Article | Subjects: | KIAA2022 NEXMIF developmental and epileptic encephalopathy epilepsy intellectual disability |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.